IRCCS Sacro Cuore

Aug 16, 2024 | cardiab.biomedcentral.com | Christopher Byrne |IRCCS Sacro Cuore |Negrar di Valpolicella

Among the 213 adult outpatients with established T2DM included in the study (45.5% women, mean age 69 ± 10 years; BMI 28.7 ± 4.7 kg/m2; HbA1c 52 ± 7 mmol/mol; median diabetes duration 11 [IQR 6–19] years), 42 patients developed the primary composite outcome during a median follow-up of 55.6 months. Of these 42 events, 12 were all-cause deaths, 9 were incident nonfatal myocardial infarctions, 12 were incident permanent AF, 4 were incident nonfatal strokes, and 5 were new hospitalizations for HF.

Jul 1, 2024 | bmcmedicine.biomedcentral.com | Christopher Byrne |Anhui Agricultural |IRCCS Sacro Cuore |Negrar di Valpolicella

JZ conceived and supervised the study, wrote the initial draft, and coordinated with all other co-authors in writing of the final version of the manuscript. LY carried out DOC test, performed statistical analysis and participated in the writing of the initial draft. KZ performed statistical analysis and participated in the writing of the initial draft.

Feb 29, 2024 | cell.com | Christopher Byrne |Lei Miao |Giovanni Targher |IRCCS Sacro Cuore

A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J. Hepatol. 2020; 73: 202-209The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol. Int. 2020; 14: 889-919Promoting the term MAFLD: China in action. Lancet Gastroenterol. Hepatol.